{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T08:48:20Z","timestamp":1777884500761,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,4,30]],"date-time":"2027-04-30T00:00:00Z","timestamp":1809043200000},"content-version":"am","delay-in-days":364,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.oret.2026.01.004","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T16:14:51Z","timestamp":1768320891000},"page":"543-551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Substance Use Disorder Interventions and Ophthalmic Outcomes for Injection Drug Use\u2013Associated Endogenous Endophthalmitis"],"prefix":"10.1016","volume":"10","author":[{"given":"Jared T.","family":"Sokol","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Krasinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George N.","family":"Papaliodis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean","family":"Eliott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric D.","family":"Gaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2026.01.004_bib1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1001\/jamaophthalmol.2020.4741","article-title":"Incidence of drug use\u2013related endogenous endophthalmitis hospitalizations in the United States, 2003 to 2016","volume":"139","author":"Mir","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2026.01.004_bib2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.15.1.111-124.2002","article-title":"Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions","volume":"15","author":"Callegan","year":"2002","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.oret.2026.01.004_bib3","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/ICU.0000000000000606","article-title":"Endogenous endophthalmitis and other ocular manifestations of injection drug use","volume":"30","author":"Luong","year":"2019","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.oret.2026.01.004_bib4","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.oret.2016.10.013","article-title":"Intravenous drug use-associated endophthalmitis","volume":"1","author":"Modjtahedi","year":"2017","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2026.01.004_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1081\/ADA-100103117","article-title":"One-, three-, and six-month outcomes after brief inpatient opioid detoxification","volume":"27","author":"Chutuape","year":"2001","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.oret.2026.01.004_bib6","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies--tackling the opioid-overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.oret.2026.01.004_bib7","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s11606-010-1311-3","article-title":"A transitional opioid program to engage hospitalized drug users","volume":"25","author":"Shanahan","year":"2010","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.oret.2026.01.004_bib8","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1001\/jama.2015.3474","article-title":"Emergency department-initiated buprenorphine\/naloxone treatment for opioid dependence: a randomized clinical trial","volume":"313","author":"D\u2019Onofrio","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.oret.2026.01.004_bib9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.15288\/jsa.2001.62.89","article-title":"Association of outpatient alcohol and drug treatment with health care utilization and cost: revisiting the offset hypothesis","volume":"62","author":"Parthasarathy","year":"2001","journal-title":"J Stud Alcohol"},{"key":"10.1016\/j.oret.2026.01.004_bib10","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s11606-017-4077-z","article-title":"Inpatient addiction consultation for hospitalized patients increases post-discharge abstinence and reduces addiction severity","volume":"32","author":"Wakeman","year":"2017","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.oret.2026.01.004_bib11","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1007\/s11606-019-05251-9","article-title":"Inpatient addiction medicine consultation and post-hospital substance use disorder treatment engagement: a propensity-matched analysis","volume":"34","author":"Englander","year":"2019","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.oret.2026.01.004_bib12","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.psym.2020.06.019","article-title":"Addiction management in hospitalized patients with intravenous drug use-associated infective endocarditis","volume":"61","author":"Ray","year":"2020","journal-title":"Psychosomatics"},{"key":"10.1016\/j.oret.2026.01.004_bib13","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.5220","article-title":"Clinical characteristics and factors associated with mortality in first-episode infective endocarditis among persons who inject drugs","volume":"1","author":"Rodger","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.oret.2026.01.004_bib14","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1093\/cid\/ciy924","article-title":"Addiction medicine consultations reduce readmission rates for patients with serious infections from opioid use disorder","volume":"68","author":"Marks","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.oret.2026.01.004_bib15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.7326\/M18-1203","article-title":"Integrating treatment at the intersection of opioid use disorder and infectious disease epidemics in medical settings: a call for action after a national academies of sciences, engineering, and medicine workshop","volume":"169","author":"Springer","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.oret.2026.01.004_bib16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/ajad.12349","article-title":"Medication-assisted treatment for hospitalized patients with intravenous-drug-use related infective endocarditis","volume":"25","author":"Suzuki","year":"2016","journal-title":"Am J Addict"},{"key":"10.1016\/j.oret.2026.01.004_bib17","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/cid\/ciaa062","article-title":"Outcomes associated with medications for opioid use disorder among persons hospitalized for infective endocarditis","volume":"72","author":"Barocas","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.oret.2026.01.004_bib19","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0161-6420(13)31255-X","article-title":"Endogenous bacterial endophthalmitis. Report of a ten-year retrospective study","volume":"101","author":"Okada","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2026.01.004_bib20","first-page":"725","article-title":"Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes","volume":"137","author":"Schiedler","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2026.01.004_bib21","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/00365540410020965","article-title":"Endogenous endophthalmitis: a 13-year review at a tertiary hospital in South Australia","volume":"37","author":"Leibovitch","year":"2005","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.oret.2026.01.004_bib22","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1097\/IAE.0b013e318185e943","article-title":"Fungal endophthalmitis: fourteen years\u2019 experience from a center in India","volume":"28","author":"Chakrabarti","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.oret.2026.01.004_bib23","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1097\/IAE.0b013e3181dd6db6","article-title":"Endogenous endophthalmitis associated with intravenous drug abuse: seven-year experience at a tertiary referral center","volume":"30","author":"Connell","year":"2010","journal-title":"Retina"},{"key":"10.1016\/j.oret.2026.01.004_bib24","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1869-5760-3-60","article-title":"Endogenous fungal endophthalmitis: risk factors, clinical features, and treatment outcomes in mold and yeast infections","volume":"3","author":"Sridhar","year":"2013","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"10.1016\/j.oret.2026.01.004_bib25","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/eye.2010.145","article-title":"Endogenous endophthalmitis: 10-year experience at a tertiary referral centre","volume":"25","author":"Connell","year":"2011","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.oret.2026.01.004_bib26","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8869590","article-title":"Endogenous endophthalmitis: a review of case series published between 2011 and 2020","volume":"2020","author":"Danielescu","year":"2020","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.oret.2026.01.004_bib27","doi-asserted-by":"crossref","first-page":"e963","DOI":"10.1111\/aos.14659","article-title":"A novel excel sheet conversion tool from Snellen fraction to LogMAR including \u201ccounting fingers\u201d, \u201chand movement\u201d, \u201clight perception\u201d and \u201cno light perception\u201d and focused review of literature of low visual acuity reference values","volume":"99","author":"Moussa","year":"2021","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.oret.2026.01.004_bib28","doi-asserted-by":"crossref","first-page":"202","DOI":"10.15585\/mmwr.mm7006a4","article-title":"Trends and geographic patterns in drug and synthetic opioid overdose deaths - United States, 2013-2019","volume":"70","author":"Mattson","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.oret.2026.01.004_bib30","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.tcm.2019.11.007","article-title":"Infective endocarditis in intravenous drug users","volume":"30","author":"Sanaiha","year":"2020","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.oret.2026.01.004_bib31","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.oret.2026.01.004_bib32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jsat.2015.05.001","article-title":"Risk factors for relapse and higher costs among Medicaid members with opioid dependence or abuse: opioid agonists, comorbidities, and treatment history","volume":"57","author":"Clark","year":"2015","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.oret.2026.01.004_bib33","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/add.13238","article-title":"Long-term outcomes after randomization to buprenorphine\/naloxone versus methadone in a multi-site trial","volume":"111","author":"Hser","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.oret.2026.01.004_bib34","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugalcdep.2015.02.030","article-title":"Long-term outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study","volume":"150","author":"Weiss","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.oret.2026.01.004_bib35","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study","volume":"169","author":"Larochelle","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.oret.2026.01.004_bib36","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.31243","article-title":"Substance use disorder program availability in safety-net and non-safety-net hospitals in the US","volume":"6","author":"Chang","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.oret.2026.01.004_bib37","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/ADM.0000000000001295","article-title":"A clinical guide to support the implementation of addiction consult services and the value of teaching and technical assistance","volume":"18","author":"Fielman","year":"2024","journal-title":"J Addict Med"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653026000047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653026000047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:27:36Z","timestamp":1777602456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653026000047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2468653026000047"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2026.01.004","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Substance Use Disorder Interventions and Ophthalmic Outcomes for Injection Drug Use\u2013Associated Endogenous Endophthalmitis","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2026.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}